NexgenRx Inc. (TSXV:NXG)
Canada flag Canada · Delayed Price · Currency is CAD
0.4500
-0.0100 (-2.17%)
Jun 9, 2026, 2:22 PM EST

NexgenRx Balance Sheet

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
4.714.781.711.881.772.32
Cash & Short-Term Investments
4.714.781.711.881.772.32
Cash Growth
148.67%180.05%-9.12%6.22%-23.74%188.92%
Accounts Receivable
1.070.730.820.730.410.48
Other Receivables
--0.050.05--
Total Trade Receivables
1.070.730.870.780.410.48
Other Current Assets
31.0226.922.0720.6915.8318.03
Total Current Assets
36.8132.424.6523.341820.83
Net Property, Plant & Equipment
0.740.80.830.810.840.5
Other Intangible Assets
1.241.42.333.154.15.12
Goodwill
1.081.081.241.241.241.24
Long-Term Investments
0.420.370.18---
Other Long-Term Assets
0.580.561.241.661.571.74
Total Assets
40.8636.630.4630.225.7529.44
Accounts Payable
11.980.51.180.921.41
Current Portion of Leases
0.060.080.110.060.040.23
Other Current Liabilities
30.726.6321.820.8415.5417.91
Total Current Liabilities
31.7628.6922.4122.0816.5119.55
Long-Term Leases
0.290.290.430.40.390.17
Total Long-Term Liabilities
0.290.290.430.40.390.17
Total Liabilities
32.0428.9822.8422.4816.919.72
Preferred Stock
1.651.651.651.651.651.65
Common Stock
4.014.014.013.8219.2919.29
Additional Paid-in Capital
4.44.44.394.384.354.3
Retained Earnings
-1.24-2.44-2.43-2.14-16.43-15.53
Shareholders' Equity
8.827.627.627.718.859.71
Total Liabilities & Equity
40.8636.630.4630.225.7529.44
Total Debt
0.350.370.530.460.430.4
Net Cash (Debt)
4.374.411.171.411.331.92
Net Cash Growth
-0.98%276.44%-17.18%6.03%-30.33%-
Net Cash Per Share
0.060.060.010.020.020.03
Book Value
8.827.627.627.718.859.71
Book Value Per Share
0.110.100.100.110.130.13
Tangible Book Value
6.55.144.063.333.513.36
Tangible Book Value Per Share
0.080.070.050.050.050.04